Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Lucid Diagnostics Inc.LUCD · Entity 6375 | General Counsel and Secretary | February 20, 2026 | February 24, 2026 |
| PAVmed Inc.PAVM · Entity 7317 | General Counsel | April 02, 2026 | April 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Lucid Diagnostics Inc.
Report date February 20, 2026 · Filed February 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 1,000,000 |
Reported balance
After 2026-02-20 transaction · row 1
1 source rowRow 1 · 2026-02-20 · Grant · Acquired 300,000 · Balance 1,000,000 F1: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed.
PAVmed Inc.
Report date April 02, 2026 · Filed April 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 115,000 |
Reported balance
After 2026-04-02 transaction · row 1
1 source rowRow 1 · 2026-04-02 · Grant · Acquired 110,000 · Balance 115,000 F1: Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 02, 2026 Filed Apr 3, 2026 20:45 UTC | PAVmed Inc. PAVM · Entity 7317 | GrantCommon stock | 110,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-26-000144 · form4.xml · nonDerivative · entry 1 Gordon Michael Adam · CIK 0001932934 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,000 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 23:25 UTC | Lucid Diagnostics Inc. LUCD · Entity 6375 | GrantCommon stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-26-000058 · form4.xml · nonDerivative · entry 1 Gordon Michael Adam · CIK 0001932934 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,000 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:13 UTC | PAVmed Inc. PAVM · Entity 7317 | GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-25-000041 · form4.xml · nonDerivative · entry 1 Gordon Michael Adam · CIK 0001932934 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 F1 · shares: Represents restricted stock granted to the reporting person under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed. F1 · price: Represents restricted stock granted to the reporting person under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 21:58 UTC | Lucid Diagnostics Inc. LUCD · Entity 6375 | GrantCommon stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003169 · form4.xml · nonDerivative · entry 1 Gordon Michael Adam · CIK 0001932934 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 700,000 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed. Read SEC document |
| May 07, 2024 Filed May 8, 2024 20:01 UTC | Lucid Diagnostics Inc. LUCD · Entity 6375 | GrantCommon stock | 400,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-009640 · form4.xml · nonDerivative · entry 1 Gordon Michael Adam · CIK 0001932934 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2026. Such restricted stock is subject to forfeiture if the requisite service period is not completed. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 20:50 UTC | Lucid Diagnostics Inc. LUCD · Entity 6375 | GrantEmployee stock option (right to buy) · Derivative | 200,000 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001062993-22-014563 · form4.xml · derivative · entry 1 Gordon Michael Adam · CIK 0001932934 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common stock · 200,000 shares Expires 2032-06-07 F1 · derivative.exercise_date: The option vests in 12 quarterly installments, with first installment vesting June 30, 2022. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 20:48 UTC | PAVmed Inc. PAVM · Entity 7317 | GrantEmployee stock option (right to buy) · Derivative | 400,000 | $0.00 Strike: $0.97 | $0.00 |
DisclosureSEC source: 0001062993-22-014562 · form4.xml · derivative · entry 1 Gordon Michael Adam · CIK 0001932934 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common stock · 400,000 shares Expires 2032-06-07 F1 · derivative.exercise_date: The option vests in 12 quarterly installments, with first installment vesting June 30, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.